Health Economic Impact of First Pass Success: An Asia-Pacific Cost Analysis of the ARISE II Study
J Stroke
.
2021 Jan;23(1):139-143.
doi: 10.5853/jos.2020.05043.
Epub 2021 Jan 31.
Authors
Leonard Yeo
1
2
,
Osama O Zaidat
3
,
Jeffrey L Saver
4
,
Heinrich P Mattle
5
,
Stephanie Hsiao Yu Lee
6
,
Emilie Kottenmeier
7
,
Heather L Cameron
8
,
Rana A Qadeer
8
,
Tommy Andersson
9
10
Affiliations
1
Division of Neurology, National University Health System, Singapore.
2
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
3
Department of Neuroscience, Mercy Health St. Vincent Mercy Hospital, Toledo, OH, USA.
4
Department of Neurology, University of California Los Angeles, Los Angeles, CA, USA.
5
Department of Neurology, Inselspital, University of Bern, Bern, Switzerland.
6
Johnson & Johnson Medical Asia Pacific, Singapore.
7
Cerenovus, Johnson & Johnson, Irvine, CA, USA.
8
EVERSANA, Burlington, ON, Canada.
9
Departments of Neuroradiology, Karolinska University Hospital and Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
10
Department of Medical Imaging, AZ Groeninge, Kortrijk, Belgium.
PMID:
33600713
PMCID:
PMC7900400
DOI:
10.5853/jos.2020.05043
No abstract available